A cerebral aneurysm is a weak spot in the wall of an artery leading to an area of the brain. This weak spot may enlarge, leading to a bulging in the artery wall, known as an aneurysm. It can rupture and lead to life-threatening bleeding in the brain, known as a subarachnoid hemorrhage (SAH). It is a serious medical condition that requires quick diagnosis and treatment. The most common risk factor for a cerebral aneurysm is high blood pressure, though other factors such as trauma to the head, heavy smoking, and certain birth defects may also be causes. If there’s a family history of cerebral aneurysm, or if a person has risk factors for aneurysms, this should be discussed with a physician. A medical evaluation is also recommended if a person has symptoms associated with a cerebral aneurysm. In some cases, a cerebral aneurysm is asymptomatic, in which case it is typically detected through a computed tomography (CT) or magnetic resonance imaging (MRI) scan of the brain. If the aneurysm is small and considered low-risk, it can be monitored regularly by imaging tests. In other cases, medical intervention is necessary to prevent the rupture of the aneurysm. Surgical treatments for a cerebral aneurysm include clipping, which involves placing a metal clip at the base of the aneurysm to stop blood flow to the aneurysm, and endovascular coiling, which involves threading tiny platinum coils through a catheter into the aneurysm to fill it and block the artery. The type of treatment that’s best depends on the characteristics of the aneurysm. If a cerebral aneurysm ruptures, it is a medical emergency requiring emergency surgery. In this case, medications may be given to manage the symptoms until surgery is possible. Depending on the severity, some patients may require intensive care and rehabilitation. Regardless of the treatment, close monitoring of the aneurysm is necessary.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom